Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XILLIX FDA APPROVED -- Ignore unavailable to you. Want to Upgrade?

To: Harry Stein who wrote (520)	1/1/2000 1:03:00 AM
From: louie	Respond to of 572

HSG ,Stein wish all of you a very Happy New Year and all the best to your family and friends.Cheers!!!!!!!!!

To: Harry Stein who wrote (520)	1/3/2000 2:46:00 AM
From: louie	Read Replies (1) \| Respond to of 572

Mr Stein,Olympus was hopping that their own country would not award the patent 5,647368 for the Life GI and Life Lung to Xillix but it was file and completed on December 20 1999.Olympus knew if that patent was Xillix ownership that would surely open the doors for further damages offered to Xillix.For Olympus to have any hope of appealing the verdict it had to prove that the technology was open domain shared by both parties,this was not proven by Olympus.In my opinion Olympus only choice is to settle out of court quickly before Xillix widens their claims even further.The price increase we have seen only indicates investors agree,and by the large blocks being push thru it looks like fund managers are taking notice.Momentum is building for this stock and if things go well in the next few quarters you will get all your investment back plus more.